AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…
Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
UK, China rush to forge business deals
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the…
Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
Hooked on rebates?: CNBC UK Exchange newsletter
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light…
How global CEOs are shifting gears
Trade tensions are rising, forcing top executives to rewrite the rulebook on how their companies operate, where they invest…